Open AccessAbstract 1051: Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth upon bevacizumab-induced hypoxia,in vivo
Author(s) -
Anna Golebiewska,
Anaïs Oudin,
Anne Steinø,
Simone P. Niclou,
Jeffrey Bacha,
Dennis Brown
Publication year - 2019
Language(s) - Uncategorized
Resource type - Conference proceedings
DOI - 10.1158/1538-7445.sabcs18-1051
Subject(s) - bevacizumab , glioblastoma , in vivo , hypoxia (environmental) , cancer research , chemistry , medicine , biology , chemotherapy , oxygen , microbiology and biotechnology , organic chemistry